Approval · Notice of Compliance 2864 · 2004
CIPRODEX: Notice of Compliance 2864
Issued May 10, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2864
- Date
- May 10, 2004
- Company
- Alcon Canada Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antibacterial, corticosteroid (otic)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CIPRODEX | 02252716 | Marketed |
Medicinal ingredients
- DEXAMETHASONE 0.1 PER
- CIPROFLOXACIN HYDROCHLORIDE 0.3 PER